Search results
15 wrz 2022 · Table 1. Eight Key Clinical Management Issues Related to the Management of Patients at Risk for and With LV Thrombus. 1. Is echocardiography adequate for detection of suspected LV thrombus, or is CMR (or cardiac CT) indicated when there is concern for LV thrombus? 2.
- View EPUB
PK u!3Yoa«, mimetypeapplication/epub+zipPK u!3Y...
- Linda S. Williams
Many diseases with specific indications for specific...
- PDF/Epub
PK u!3Yoa«, mimetypeapplication/epub+zipPK u!3Y...
- Trial
Background—The Randomized Evaluation of Long-term...
- Results From the GEIST
Left ventricular (LV) thrombus formation is a well‐known...
- Intraventricular Thrombus Formation and Embolism in Takotsubo Syndrome
Objective: Takotsubo syndrome (TTS) is characterized by...
- Stroke
National Center. 7272 Greenville Ave.Dallas, TX 75231....
- Peripartum Cardiomyopathy
Peripartum cardiomyopathy is a potentially life-threatening...
- View EPUB
23 wrz 2022 · This AHA scientific statement was commissioned with the goals of addressing eight key clinical management questions related to LV thrombus, including the prevention and treatment after myocardial infarction (MI), prevention and treatment in dilated cardiomyopathy (DCM), management of mural (laminated) thrombus, imaging of LV thrombus, DOACs as ...
14 wrz 2022 · Is anticoagulation really indicated for laminated thrombus (not a more mobile, round, mural thrombus)? Is DOAC a reasonable alternative to warfarin for the prevention and treat-ment of LV thrombus? What management options are there in patients with persistent LV throm-bus despite therapy?
From the ESC Working Group on Thrombosis. Date. Title. 01/10/2024. Targeting Fibrinolytic Inhibition for Venous Thromboembolism Treatment: Overview of an Emerging Therapeutic Approach. 01/10/2024. Aspirin-free strategy for percutaneous coronary intervention in acute coronary syndrome based on the subtypes of acute coronary syndrome and high ...
Left ventricular (LV) thrombus is a feared complication of LV dysfunction associated with high rates of systemic embolism, morbidity, and mortality. Traditionally, LV thrombus has been associated with acute myocardial infarction (MI).
Introduction Left ventricular thrombus (LVT) is a frequent complication of left ventricular systolic dysfunction (1). Incidence following acute myocardial infarction is estimated at 13–20% and up to 15% in with non-ischaemic cardiomyopathy (2, 3). Once diagnosed, guidelines recommend anticoagulation with vitamin K antagonists (VKA) to reduce ...
Management of LV thrombus (LVT) is challenging and crucial to prevent the potential development of thromboembolic complications such as stroke. Anticoagulation with warfarin is recommended for the prevention of thromboembolic events, but novel oral anticoagulants (NOAC) have been used in clinical practice without supporting evidence.
